01.12.2018 | Lungenkarzinome | Case report | Ausgabe 1/2018 Open Access

Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
- Zeitschrift:
- BMC Cancer > Ausgabe 1/2018